Elke Jahn
Labcorp Drug Development, United States
Senior Director, Operational Strategy & Planning Phase IV Solutions
As Leader of the Phase IV Strategy & Planning (S&P) team, Elke is globally accountable for providing client specific strategies to address the need for Real World Evidence generation and Phase IIIb/IV Clinical Trial execution requests. This includes proposal generation on a global basis. Elke joined Covance 6+ years ago being accountable for the European and APAC portfolio delivery within the operations group. Since 2016, she leads the Phase IV Solutions S&P team. She has over 20 years’ experience holding various operational and strategic functions in the Medical Affairs arena in the Pharmaceutical Industry and CRO (Sanofi, Novo-Nordisc, Menarini Group, Actelion, Abbvie, Covance).